NASDAQ : BGM
BGM Group Ltd. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · China
Last price 9.54 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 127.40M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BGM Group Ltd. (BGM) reported revenue of 47.90M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Revenue | 47.90M | 37.92M | 25.10M | 46.47M |
| Cost of Revenue | 39.80M | 31.61M | 20.98M | 44.72M |
| Gross Profit | 8.11M | 6.31M | 4.11M | 1.75M |
| Selling, General & Admin | 18.94M | 18.22M | 3.32M | 3.79M |
| Research & Development | 387.21K | 672.67K | 1.36M | 568.47K |
| Operating Expenses | 19.33M | 18.89M | 4.68M | 4.36M |
| Operating Income | -11.22M | -12.58M | -563.77K | -2.61M |
| Interest Expense | -11.32K | -639.51K | ||
| Interest & Investment Income | 64.32K | 83.13K | 99.19K | |
| Earnings From Equity Investments | -1.64M | -427.70K | -204.65K | |
| Other Non Operating Income (Expenses) | 194.54K | 687.23K | 191.57K | 131.37K |
| EBT Excluding Unusual Items | -12.62M | -12.24M | -1.22M | -2.38M |
| Gain (Loss) on Sale of Investments | -4.16M | -7.70M | -920.79K | -5.52M |
| Pretax Income | -16.78M | -19.94M | -2.14M | -7.90M |
| Income Tax Expense | 4.83M | 277.79K | -619.98K | 219.17K |
| Earnings From Continuing Operations | -21.60M | -20.22M | -1.52M | -8.12M |
| Minority Interest in Earnings | 420.47K | 274.77K | 74.33K | 341.45K |
| Net Income | -21.18M | -19.94M | -1.44M | -7.78M |
| Net Income to Common | -21.18M | -19.94M | -1.44M | -7.78M |
| Shares Outstanding (Basic) | 6.34M | 3.78M | 240.88K | 240.88K |
| Shares Outstanding (Diluted) | 6.34M | 3.78M | 240.88K | 240.88K |
| EPS (Basic) | -3.34 | -5.28 | -5.99 | -32.30 |
| EPS (Diluted) | -3.36 | -5.40 | -6.00 | -32.40 |
| Free Cash Flow | 1.46M | -4.44M | -2.31M | -1.54M |
| Free Cash Flow Per Share | 0.23 | -1.18 | -9.59 | -6.38 |
| Gross Margin | 16.93% | 16.64% | 16.39% | 3.77% |
| Operating Margin | -23.43% | -33.18% | -2.25% | -5.62% |
| Profit Margin | -44.22% | -52.59% | -5.75% | -16.74% |
| Free Cash Flow Margin | 3.05% | -11.70% | -9.20% | -3.31% |
| EBITDA | -9.25M | -11.12M | 673.46K | -1.47M |
| EBITDA Margin | -19.31% | -29.32% | 2.68% | -3.16% |
| D&A For EBITDA | 1.97M | 1.46M | 1.24M | 1.14M |
| EBIT | -11.22M | -12.58M | -563.77K | -2.61M |
| EBIT Margin | -23.43% | -33.18% | -2.25% | -5.62% |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Cash & Equivalents | 11.52M | 9.82M | 9.82M | |
| Trading Asset Securities | 28.40K | 994.89K | 8.32M | |
| Cash & Short-Term Investments | 11.55M | 10.81M | 18.14M | |
| Accounts Receivable | 7.25M | 7.17M | 4.88M | |
| Other Receivables | 525.73K | 9.18M | 192.39K | |
| Receivables | 7.78M | 16.34M | 5.07M | |
| Inventory | 18.96M | 20.10M | 5.05M | |
| Restricted Cash | 867.00 | 870.00 | ||
| Other Current Assets | 7.44M | 4.29M | 1.51M | |
| Total Current Assets | 45.72M | 51.55M | 29.77M | |
| Property, Plant & Equipment | 15.20M | 15.07M | 14.25M | |
| Long-Term Investments | 10.40M | 11.50M | 3.36M | |
| Goodwill | 360.29M | 350.85M | ||
| Other Intangible Assets | 4.34M | 4.49M | 4.54M | |
| Long-Term Deferred Tax Assets | 248.43K | 246.40K | 424.47K | |
| Other Long-Term Assets | 355.07K | 117.48K | 660.57K | |
| Total Assets | 436.55M | 433.81M | 53.00M | |
| Accounts Payable | 6.35M | 6.56M | 4.13M | |
| Accrued Expenses | 25.06M | 28.91M | 1.23M | |
| Short-Term Debt | 1.08M | 1.62M | ||
| Current Portion of Leases | 88.59K | 240.94K | ||
| Current Income Taxes Payable | 713.15K | 1.17K | ||
| Current Unearned Revenue | 3.59M | 3.22M | 568.50K | |
| Other Current Liabilities | 401.38K | 340.62K | 2.85M | |
| Total Current Liabilities | 36.57M | 41.60M | 8.78M | |
| Long-Term Leases | 2.60K | 79.31K | ||
| Long-Term Unearned Revenue | 207.81K | 240.15K | 134.39K | |
| Total Liabilities | 36.78M | 41.92M | 8.91M | |
| Common Stock | 1.67M | 1.67M | 59.58K | |
| Additional Paid-In Capital | 399.02M | 399.02M | 36.41M | |
| Retained Earnings | -14.43M | -12.33M | 7.62M | |
| Comprehensive Income & Other | 11.98M | 2.52M | -1.34M | |
| Total Common Equity | 398.24M | 390.88M | 42.74M | |
| Minority Interest | 1.53M | 1.02M | 1.35M | |
| Shareholders' Equity | 399.77M | 391.90M | 44.09M | |
| Total Liabilities & Equity | 436.55M | 433.81M | 53.00M | |
| Total Debt | 1.18M | 1.94M | ||
| Net Cash (Debt) | 10.37M | 8.88M | 18.14M | |
| Net Cash Per Share | 1.64 | 2.35 | 75.31 | |
| Filing Date Shares Outstanding | 6.69M | 6.69M | 240.88K | 240.88K |
| Total Common Shares Outstanding | 6.69M | 6.69M | 240.88K | 240.88K |
| Working Capital | 9.15M | 9.95M | 20.99M | |
| Book Value Per Share | 59.55 | 58.45 | 177.45 | |
| Tangible Book Value | 33.62M | 35.54M | 38.20M | |
| Tangible Book Value Per Share | 5.03 | 5.31 | 158.60 | |
| Machinery | 28.78M | 27.44M | 19.20M | |
| Construction In Progress | 136.77K | 4.03M | 5.64M |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Net Income | -21.18M | -19.94M | -1.44M | -7.78M |
| Depreciation & Amortization | 1.97M | 1.46M | 1.24M | 1.14M |
| Asset Writedown & Restructuring Costs | 195.91K | 195.91K | 526.00 | |
| Loss (Gain) From Sale of Investments | 4.16M | 7.70M | 920.79K | 5.53M |
| Loss (Gain) on Equity Investments | 1.64M | 427.70K | 204.65K | |
| Stock-Based Compensation | 10.23M | 10.23M | ||
| Provision & Write-off of Bad Debts | -307.95K | 94.12K | 127.57K | 37.88K |
| Other Operating Activities | 5.16M | 647.66K | -1.29M | 272.31K |
| Change in Accounts Receivable | 1.31M | -3.35M | 378.39K | -1.22M |
| Change in Inventory | 3.74M | -1.85M | 958.65K | 3.40M |
| Change in Accounts Payable | -6.61M | -1.83M | 378.98K | -1.62M |
| Change in Unearned Revenue | -1.87M | 2.78M | -668.24K | 376.34K |
| Change in Income Taxes | 485.38K | 577.52K | 101.84K | -612.27K |
| Change in Other Net Operating Assets | 4.25M | 482.83K | -363.92K | 785.64K |
| Operating Cash Flow | 3.17M | -2.37M | 544.24K | 312.21K |
| Capital Expenditures | -1.71M | -2.07M | -2.85M | -1.85M |
| Cash Acquisitions | 2.39M | 2.39M | -28.36K | |
| Sale (Purchase) of Intangibles | 27.04K | -121.38K | -1.08M | -1.87M |
| Investment in Securities | 1.91M | -370.52K | 4.86M | -1.00M |
| Other Investing Activities | 56.20K | |||
| Investing Cash Flow | 2.60M | -162.91K | 983.42K | -4.74M |
| Short-Term Debt Issued | 2.17M | 496.22K | ||
| Long-Term Debt Issued | 1.01M | |||
| Total Debt Issued | 1.02M | 3.18M | 496.22K | |
| Short-Term Debt Repaid | -562.94K | -491.73K | -141.78K | |
| Long-Term Debt Repaid | -1.54M | |||
| Total Debt Repaid | -574.98K | -562.94K | -491.73K | -1.69M |
| Net Debt Issued (Repaid) | 444.21K | 2.62M | -491.73K | -1.19M |
| Common Dividends Paid | -1.79M | |||
| Other Financing Activities | 56.71K | |||
| Financing Cash Flow | -5.31M | 2.62M | -491.73K | -2.92M |
| Foreign Exchange Rate Adjustments | 363.75K | -80.39K | 1.31M | -151.45K |
| Net Cash Flow | 821.43K | 3.19K | 2.34M | -7.50M |
| Free Cash Flow | 1.46M | -4.44M | -2.31M | -1.54M |
| Free Cash Flow Margin | 3.05% | -11.70% | -9.20% | -3.31% |
| Free Cash Flow Per Share | 0.23 | -1.18 | -9.59 | -6.38 |
| Levered Free Cash Flow | 11.24M | 3.50M | ||
| Unlevered Free Cash Flow | 11.24M | 3.50M | ||
| Cash Interest Paid | 55.00K | 35.33K | 4.26K | 3.66K |
| Cash Income Tax Paid | 167.54K | 71.28K | 21.91K | 27.44K |
| Change in Working Capital | 1.30M | -3.19M | 785.70K | 1.11M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Market Capitalization | 127.40M | 1.88B | ||
| Enterprise Value | 117.03M | 1.87B | ||
| Last Close Price | 9.54 | 307.20 | ||
| PS Ratio | 2.66 | 49.68 | ||
| PB Ratio | 0.16 | 4.81 | ||
| P/TBV Ratio | 3.79 | 53.00 | ||
| EV/Sales Ratio | 2.44 | 49.38 | ||
| Debt / Equity Ratio | 0.00 | 0.01 | ||
| Debt / FCF Ratio | 0.81 | |||
| Net Debt / Equity Ratio | -0.03 | -0.02 | -0.41 | |
| Net Debt / EBITDA Ratio | 1.12 | 0.80 | -26.94 | |
| Net Debt / FCF Ratio | -7.10 | 2.00 | 7.86 | |
| Asset Turnover | 0.15 | 0.16 | ||
| Inventory Turnover | 2.86 | 2.51 | ||
| Quick Ratio | 0.53 | 0.65 | 2.65 | |
| Current Ratio | 1.25 | 1.24 | 3.39 | |
| Return on Equity (ROE) | -7.41% | -9.27% | ||
| Return on Assets (ROA) | -2.18% | -3.23% | ||
| Return on Capital Employed (ROCE) | -2.80% | -3.20% | -1.30% | |
| Earnings Yield | -35.20% | -1.06% | ||
| FCF Yield | 1.15% | -0.24% | ||
| Buyback Yield / Dilution | -879.66% | -1,467.31% |